MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MAGUS, R. D.
Right arrow Articles by FOUTS, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAGUS, R. D.
Right arrow Articles by FOUTS, J. R.

Molecular Pharmacology, Vol 4, 465-470, Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics

Inhibition of Tryptophan Pyrrolase Induction by Carbon Tetrachloride in Rats

RAYMOND D. MAGUS 1 and JAMES R. FOUTS 1

1 Department of Pharmacology, University of Iowa College of Medicine, Iowa City, Iowa 62240

The inducing action of hydrocortisone and L-tryptophan on hepatic tryptophan pyrrolase in rats treated previously with CCl4 was studied. CCl4 exhibited a dose-dependent (and time-dependent) inhibitory action on the hematin-activated (apoenzyme) form of tryptophan pyrrolase but had no effect on basal holoenzyme activity. A low dose of CCl4 (0.1 ml/kg) abolished induction of the holoenzyme by hydrocortisone but had little effect on the tryptophan-induced holoenzyme or total enzyme activity. This inhibitory action of CCl4 required between 6 and 12 hr of exposure of the animal to CCl4 in vivo, i.e., prior to administration of the inducing agents. A 10-fold increase in CCl4 dose to 1.0 ml/kg did not abolish the inducing action of tryptophan; however, the enzyme response to tryptophan administration was appreciably reduced in rats receiving the higher CCl4 dose.

Note:
ACKNOWLEDGMENT This investigation was supported by Grants GM12675 and 5-T01-GM 01308 from the National Institute of General Medical Sciences.

Submitted on February 26, 1968
Revised on June 3, 1968







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics